Andy Long

Senior Scientist @Formycon AG

Munich, DE
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Nov 2022 — Present

Senior Scientist @Formycon AG

View department →

Munich, DE

Optimized clone selection and upstream process performance to meet the rigorous demands of competitive biosimilar development projects. Responsibilities included:Presenting technical findings and data-driven recommendations across cross-functional internal meetings, including stakeholders from R&D, manufacturing, and regulatory affairs.Continuously refining production parameters to enhance antibody yield and quality, ensuring alignment with biosimilarity requirements.Applying analytical insights and process adaptability to achieve consistent and scalable antibody expression across selected clones.

EDUCATION

2007 — 2013

University of Oklahoma Health Campus

Doctor of Philosophy (PhD), Biochemistry and Molecular Biology

2003 — 2007

University of Oklahoma

Minor, Italian

2003 — 2007

University of Oklahoma

BS, Biochemistry

SKILLS

Cell CulturePurificationProtein ExpressionTransfectionMolecular CloningBiochemistryWestern BlottingManagementLeadershipProtein ChemistryPcrMammalian Cell CultureTissue CultureMolecular BiologyProject ManagementMicrosoft OfficeSds-PageFlow CytometryTeamworkElisaLife SciencesMitochondriaGeneticsBiotechnologyProtein Purification

ABOUT ANDY LONG

Built and scaled a new operational unit (mammalian cell culture department) within a CRO environment, establishing governance, workflows, and stakeholder interfaces from the ground up.• Managed and grew strategic client relationships by acting as a trusted advisor, aligning scientific strategy with business objectives and long-term partnerships.• Operated at the interface of discovery, development, and GMP manufacturing, enabling informed decision-making that reduced downstream risk and supported compliant execution.• Known for navigating ambiguity, communicating transparently during setbacks, and driving alignment across diverse stakeholders to achieve sustainable outcomes.• Stabilized and enabled continuation of high-risk development programs by applying risk-based decision frameworks aligned with cost, compliance, and long-term execution.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Andy Long — Senior Scientist at Formycon AG in Munich, DE | Unifers